Document ID: chunk:federal_register_of_legislation:F2022L00276:reg:9:p4
Version: federal_register_of_legislation:F2022L00276
Segment Type: reg
Provision Reference: reg 9 (pt 4/6)
Character Range: 12702–16195

haematoma.
(40)      having non-infectious myocarditis at the time of the clinical worsening of heart block;
Note 1: Non-infectious myocarditis can be acute or chronic.
             Note 2: Non-infectious myocarditis can be of autoimmune, infiltrative or immunological origin. Examples of causes of non-infectious myocarditis include immune checkpoint inhibitor therapy and giant cell myocarditis.
(41)      having viral myocarditis at the time of the clinical worsening of heart block;
Note 1: Viral myocarditis can be acute or chronic.
             Note 2: Examples of viral causes of myocarditis include severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), human immunodeficiency virus, group B coxsackieviruses and dengue virus.
(42)      having a non-viral infection of the myocardium at the time of the clinical worsening of heart block;
             Note 1: A non-viral infection of the myocardium can be caused by bacteria, protozoa, fungi or parasites.
Note 2: Examples of non-viral infections of the myocardium include:
               (a)        Borrelia burgdorferi (Lyme disease);
               (b)       Corynebacterium diphtheriae (diphtheria);
               (c)        Cysticercus species (cysticercosis);
               (d)       Echinococcus species (hydatid disease);
               (e)        Treponema pallidum (tertiary syphilis);
               (f)        Trypanosoma cruzi (Chagas disease); and
               (g)       Toxoplasma gondii (toxoplasmosis).
(43)      having infective endocarditis at the time of the clinical worsening of heart block;
(44)      having a mineral or electrolyte abnormality from the specified list of mineral or electrolyte abnormalities at the time of the clinical worsening of heart block;
            Note: specified list of mineral or electrolyte abnormalities is defined in the Schedule 1 - Dictionary.
(45)      taking a drug from the specified list of drugs within the 3 weeks before the clinical worsening of heart block;
Note: specified list of drugs is defined in the Schedule 1 - Dictionary.
(46)      taking chloroquine or hydroxychloroquine for at least 1 year before the clinical worsening of heart block;
(47)      having ingested a plant containing cardiac glycosides within the 7 days before the clinical worsening of heart block;
            Note: Examples of plants containing cardiac glycosides include the pong-pong tree (Cerbera odollam) and foxglove (Digitalis purpurea).
(48)      having acute pyrethroid poisoning after inhaling, ingesting or having cutaneous contact with a pyrethroid insecticide within the 3 days before the clinical worsening of heart block;
            Note: Clinical features of acute pyrethroid poisoning may include dermal, neurological, gastrointestinal and respiratory symptoms. Cardiac involvement can lead to chest pain, tachycardia, hypertension, hypotension and arrhythmia.
(49)      experiencing penetrating trauma to the heart within the 1 year before the clinical worsening of heart block;
(50)      having a thoracic surgical procedure or an invasive cardiac procedure within the 1 year before the clinical worsening of heart block;
            Note 1: Examples of thoracic surgical procedures include vascular, mediastinal, pulmonary and chest wall surgery.
Note 2: Examples of invasive cardiac procedures include:
               (a)        alcohol septal ablation;
               (b)       catheter ablation of arrhythmias;
               (c)        open heart surgery;